Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Modelling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource

Maguire, Emily, Winston, Jincy, Ellwood, Sarah, O'Donoghue, Rachel, Shaw, Bethany, Morales, Atahualpa, Keat, Samuel, Evans, Alexandra, Marshall, Rachel, Luckcuck, Lauren, Brown, Laura, Salis, Elisa, Leonenko, Ganna ORCID: https://orcid.org/0000-0001-8025-661X, Denning, Nicola, Allen, Nicholas ORCID: https://orcid.org/0000-0003-4009-186X, Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483, Webber, Caleb ORCID: https://orcid.org/0000-0001-8063-7674, Taylor, Philip R. ORCID: https://orcid.org/0000-0003-0163-1421, Sims, Rebecca ORCID: https://orcid.org/0000-0002-3885-1199, Cowley, Sally A., Williams, Julie ORCID: https://orcid.org/0000-0002-4069-0259, Carpanini, Sarah M., Hall-Roberts, Hazel and EADB Consortium 2025. Modelling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource. Stem Cell Reports
Item availability restricted.

[thumbnail of Provisional File] PDF (Provisional File) - Accepted Post-Print Version
Download (17kB)
[thumbnail of FINAL_IPMAR resource paper_June2025.pdf] PDF - Accepted Post-Print Version
Restricted to Repository staff only

Download (1MB)

Abstract

Common forms of Alzheimer’s disease (AD) are complex and polygenic. We have created a research resource that seeks to capture the extremes of polygenic risk in a collection of human induced pluripotent stem cell (iPSC) lines from over 100 donors: The IPMAR Resource (IPSC Model for Alzheimer’s disease Research). Donors were selected from a large UK cohort of 6,000+ research-diagnosed early or late onset AD cases, and elderly cognitively healthy controls, many of whom have lived through the age of risk for disease development (>85 years). We include iPSC with extremes of global AD polygenic risk (high risk late-onset AD: 34; high risk early-onset AD: 29; low risk control: 27) as well as those reflecting complement pathway-specific genetic risk (high risk AD: 9; low risk controls: 10). All iPSC have associated clinical, longitudinal and genetic datasets, and will be available through collaboration or from cell (EBiSC) and data (DPUK) repositories.

Item Type: Article
Status: In Press
Schools: Schools > Medicine
Schools > Biosciences
Publisher: Cell Press
ISSN: 2213-6711
Date of First Compliant Deposit: 19 June 2025
Date of Acceptance: 5 June 2025
Last Modified: 24 Jun 2025 10:56
URI: https://orca.cardiff.ac.uk/id/eprint/178829

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics